dc.contributor.author |
Monteagudo, Mònica |
dc.contributor.author |
Barrecheguren, Miriam |
dc.contributor.author |
Solntseva, Iryna |
dc.contributor.author |
Dhalwani, Nafeesa |
dc.contributor.author |
Booth, Alison |
dc.contributor.author |
Núñez, Alexa |
dc.contributor.author |
Lambrelli, Dimitra |
dc.contributor.author |
Miravitlles, Marc |
dc.date |
2021 |
dc.identifier |
https://ddd.uab.cat/record/239241 |
dc.identifier |
urn:10.1038/s41533-021-00227-x |
dc.identifier |
urn:oai:ddd.uab.cat:239241 |
dc.identifier |
urn:pmcid:PMC7985144 |
dc.identifier |
urn:pmc-uid:7985144 |
dc.identifier |
urn:pmid:33753747 |
dc.identifier |
urn:oai:pubmedcentral.nih.gov:7985144 |
dc.format |
application/pdf |
dc.language |
eng |
dc.publisher |
|
dc.relation |
NPJ primary care respiratory medicine ; Vol. 31 (march 2021) |
dc.rights |
open access |
dc.rights |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
dc.rights |
https://creativecommons.org/licenses/by/4.0/ |
dc.subject |
Epidemiology |
dc.subject |
Chronic obstructive pulmonary disease |
dc.title |
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
dc.type |
Estudi clínic |
dc.description.abstract |
There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalonia from 2011 to 2015 aimed to identify the use of TT in patients with newly diagnosed COPD. A total of 69,668 newly diagnosed patients were identified of whom 11,524 (16.5%) initiated TT, of whom 8626 initiated TT at or immediately after COPD diagnosis. Among them, 72.3% were GOLD A/B, 14.6% were frequent exacerbators, and 7.1% had asthma-COPD overlap (ACO). Variables associated with TT initiation were: male sex, older age, previous exacerbations, ACO, a previous treatment regimen containing an inhaled corticosteroid, previous pneumonia, and history of lung cancer. A significant number of COPD patients in Primary Care initiated TT shortly after or even before an established COPD diagnosis. |